Summary
Eli Lilly and Company (LLY) filed an 8-K on April 24, 2013, to report its first-quarter 2013 financial results. The filing includes a press release and related financial statements, detailing the company's performance for the three-month period ending March 31, 2013. Notably, the company highlighted its use of non-GAAP financial measures, such as non-GAAP net income and earnings per share, which it believes offer valuable insights into ongoing operations and facilitate period-over-period comparisons by excluding items that can be highly variable and difficult to predict. Investors should pay close attention to the company's rationale for using these non-GAAP metrics, as they are presented alongside GAAP figures and are intended to complement, rather than replace, traditional financial reporting. Management utilizes these non-GAAP measures internally for performance evaluation and resource allocation. The filing also indicates that prospective earnings guidance may be subject to adjustments similar to those excluded in non-GAAP reporting, underscoring the importance of reviewing the full context of financial disclosures.
Key Highlights
- 1Company reported first-quarter 2013 financial results via an 8-K filing on April 24, 2013.
- 2The filing includes a press release and financial statements for the three-month period ending March 31, 2013.
- 3Eli Lilly utilized non-GAAP financial measures, including non-GAAP net income and earnings per share, in its reporting.
- 4The company believes non-GAAP measures provide useful insights into ongoing operations and aid in meaningful period-over-period comparisons.
- 5Non-GAAP measures exclude highly variable and unpredictable items that could significantly impact reported operations.
- 6Management uses non-GAAP metrics internally for business performance evaluation and resource allocation.
- 7The filing emphasizes that non-GAAP measures should be considered in addition to, not as a substitute for, GAAP financial statements.